Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

Zimmer L., Goldinger S., Hofmann L., Loquai C., Ugurel S., Thomas I., Schmidgen M., Gutzmer R., Utikal J., Göppner D., Hassel J., Meier F., Tietze J., Forschner A., Weishaupt C., Leverkus M., Wahl R., Dietrich U., Garbe C., Kirchberger M., Eigentler T., Berking C., Gesierich A., Krackhardt A., Schadendorf D., Schuler G., Dummer R., Heinzerling L. (2016)
In: European Journal of Cancer, 60(null)
Type of Publication: Research article (journal)

Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): A multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

Weishaupt C., Strölin A., Kahle B., Kreuter A., Schneider S., Gerss J., Eveslage M., Drabik A., Goerge T. (2016)
In: The Lancet Haematology, 3(2)
Type of Publication: Research article (journal)

Radiosensitization by BRAF Inhibitor therapy - machanism and frequency of toxicity in melanoma patients

Hecht M, Zimmer L, Loquai C, Weishaupt C, Gutzmer R, Schuster B, Gleisner S, Schulze B, Goldinger SM, Berking C, Forschner A, Clemens P, Grabenbauer G, Müller-Benne T, Bauch J, Eich HT, Grabbe S, Schadendorf S, Schuler G, Keikavoussi P, Semrau S, Fietkau R, Diestel LV, Heinzerling L (2015)
In: Ann Oncol, 26(6)
Type of Publication: Research article (journal)

Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma

Elsayad K, Kriz J, Moustakis C, Scobioala S, Reinartz G, Haverkamp U, Willich N, Weishaupt C, Stadler R, Sunderkötter C, Eich HT (2015)
In: Int J Radiat Oncol Biol Phys, 93(5)
Type of Publication: Research article (journal)

Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high-risk MC1R/CDKN2A genotype patient

Böhm M., Jagirdar K., Sturm R., König S., Bauer J., Metze D., Luger T., Weishaupt C. (2015)
In: Journal of the European Academy of Dermatology and Venereology, null(null)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma Zimmer L., Apuri S., Eroglu Z., Kottschade L., Forschner A., Gutzmer R., Schlaak M., Heinzerling L., Krackhardt A., Loquai C., Markovic S., Joseph R., Markey K., Utikal J., Weishaupt C., Goldinger S., Sondak V., Zager J., Schadendorf D., Khushalani N. (2017) In: European Journal of Cancer, 75(null) Type of Publication: Research article (journal)
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Zimmer L., Goldinger S., Hofmann L., Loquai C., Ugurel S., Thomas I., Schmidgen M., Gutzmer R., Utikal J., Göppner D., Hassel J., Meier F., Tietze J., Forschner A., Weishaupt C., Leverkus M., Wahl R., Dietrich U., Garbe C., Kirchberger M., Eigentler T., Berking C., Gesierich A., Krackhardt A., Schadendorf D., Schuler G., Dummer R., Heinzerling L. (2016) In: European Journal of Cancer, 60(null) Type of Publication: Research article (journal)
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy Hofmann L., Forschner A., Loquai C., Goldinger S., Zimmer L., Ugurel S., Schmidgen M., Gutzmer R., Utikal J., Göppner D., Hassel J., Meier F., Tietze J., Thomas I., Weishaupt C., Leverkus M., Wahl R., Dietrich U., Garbe C., Kirchberger M., Eigentler T., Berking C., Gesierich A., Krackhardt A., Schadendorf D., Schuler G., Dummer R., Heinzerling L. (2016) In: European Journal of Cancer, 60(null) Type of Publication: Research article (journal)
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): A multicentre, single-arm, open-label, phase 2a, proof-of-concept trial Weishaupt C., Strölin A., Kahle B., Kreuter A., Schneider S., Gerss J., Eveslage M., Drabik A., Goerge T. (2016) In: The Lancet Haematology, 3(2) Type of Publication: Research article (journal)
Mycosis fungoides, Sezary syndrome and cutaneous B-cell lymphoma: Cutaneous lymphomas Moritz R., Weishaupt C. (2016) In: Haut, 27(3) Type of Publication: Review (journal)
Radiosensitization by BRAF Inhibitor therapy - machanism and frequency of toxicity in melanoma patients Hecht M, Zimmer L, Loquai C, Weishaupt C, Gutzmer R, Schuster B, Gleisner S, Schulze B, Goldinger SM, Berking C, Forschner A, Clemens P, Grabenbauer G, Müller-Benne T, Bauch J, Eich HT, Grabbe S, Schadendorf S, Schuler G, Keikavoussi P, Semrau S, Fietkau R, Diestel LV, Heinzerling L (2015) In: Ann Oncol, 26(6) Type of Publication: Research article (journal)
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients Hecht M., Zimmer L., Loquai C., Weishaupt C., Gutzmer R., Schuster B., Gleisner S., Schulze B., M. Goldinger S., Berking C., Forschner A., Clemens P., Grabenbauer G., Müller-Brenne T., Bauch J., Eich H., Grabbe S., Schadendorf D., Schuler G., Keikavoussi P., Semrau S., Fietkau R., Distel L., Heinzerling L. (2015) In: Annals of Oncology, 26(6) Type of Publication: Research article (journal)
Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma Elsayad K, Kriz J, Moustakis C, Scobioala S, Reinartz G, Haverkamp U, Willich N, Weishaupt C, Stadler R, Sunderkötter C, Eich HT (2015) In: Int J Radiat Oncol Biol Phys, 93(5) Type of Publication: Research article (journal)
Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia Hillgruber C., Pöppelmann B., Weishaupt C., Steingräber A., Wessel F., Berdel W., Gessner J., Ho-Tin-Noé B., Vestweber D., Goerge T. (2015) In: Journal of Experimental Medicine, 212(8) Type of Publication: Research article (journal)
Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high-risk MC1R/CDKN2A genotype patient Böhm M., Jagirdar K., Sturm R., König S., Bauer J., Metze D., Luger T., Weishaupt C. (2015) In: Journal of the European Academy of Dermatology and Venereology, null(null) Type of Publication: Research article (journal)